Thus, [68Ga]Ga-PSMA-11 PET-CT improved the N staging but not the T staging in patients with intermediate-to-high-risk prostate cancer scheduled for radical prostatectomy. The gene discussed is FOLH1; the disease is prostate carcinoma.